TPI-287
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for TPI-287, covering 2007-10-15 to 2019-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma [Phase 1, Phase 2]